Ribozyme-mediated repair of RNAs encoding mutant tumor suppressors

Cytokines and Molecular Therapy

Volumn 2, Issue 3, 1996, Pages 201-206

  Sullenger, Bruce A ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ribozyme; RNA repair; RNA splicing 1996 martin dunitz ltd; Tumor suppressor

Indexed keywords

MESSENGER RNA; PROTEIN P53; RIBOZYME;

CELL TRANSFORMATION; CONFERENCE PAPER; GENE MUTATION; GENE THERAPY; PRIORITY JOURNAL; RNA SPLICING; TETRAHYMENA; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE THERAPY; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; NEOPLASMS; RNA SPLICING; RNA, CATALYTIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0029803204     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sullenger BA, Cech TR, Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature (1994) 371: 619-22.
2. Sullenger BA, Cech TR, RNA repair: a new possibility for gene therapy. J NIH Res (1995) 7: 46-7.
3. Sullenger BA, Revising messages traveling along the cellular information superhighway. Chew Biol (1995) 2:249-53.
4. Moore MJ, Query CC, Sharp PA, Splicing of precursors to mRNAs by the spliceosome. In: The RNA World (ed RF Gestsland, JF Atkins) 303-76. Cold Spring Harbor Laboratory Press, New York, 1993.
5. Ruby SW Abelson J, Pre-mRNA splicing in yeast. Trends Genet (1991) 7: 79-85.
6. Guthrie C, Messenger RNA splicing in yeast: clues to why the spliceosome is a ribonucleoprotein. Science (1991) 253: 157-63.
7. Green MR, Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Annu Rev Cell Biol (1991) 7: 559-99.
8. Bass BL, RNA editing: new uses for old players in the RNA world. In: The RNA World (ed RF Gestsland, JF Atkins) 383-418. Cold Spring Harbor Laboratory Press, New York, 1993.
9. Benne RJ, van der Burg J, Brakenhoff JP et al, Major transcript of the frameshifted coxll gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA. Cell (1986) 46: 819-26.
10. Sollner-Webb B, RNA editing. Cnrr Opin Cell Biol (1991) 3: 1056-61.
11. Cech TR, Self-splicing of group I introns. Annu Rev Biochem (1990) 59: 543-68.
12. Morgan RA, Anderson WF, Human gene therapy. Annu Rev Biochem (1993) 62: 191-217.
13. Wu X, Levine AJ, p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sei USA (1994) 91: 3602-6.
14. Qin X-Q, Livingston DM, Kaelin WG, Adams PD, Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sei USA (1994) 91: 10 918-22.
15. Shan B, Lee W-H, Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol CellBiol (1994) 14: 8166-73.
16. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR, E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Fzro/(1995) 69: 2491-500.
17. Weinberg RA, The retinoblastoma gene and gene product. Cancer Suru (1992) 12:43-57.
18. Huang H-JS, Yee J-K, Shew J-Y et al, Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (1988) 242: 1563-6.
19. Bookstein R, Shew J-Y, Chen P-H et al, Suppression of tumorgenisity of human prostate carcinoma cells by replacing a mutated RB gene. Science (1990) 247: 712-15.
20. Woodworm CD, Wang H, Simpson S et al, Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human papillomavirus expressing cell lines. Cell Growth Differ (1993) 4: 357-76.
21. Rossi JJ, Ribozymes. Ctirr Opin Biotechnol (1992) 3: 3-7.
22. Yu M, Poeschla E, Wong-Staal F, Progress towards gene therapy for HIV infection. Gene Ther (1994) 1: 13-26.
23. Sullenger BA, Cech TR, Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science (1993) 262: 1566-9.
24. Levine AJ, Momand J, Finlay CA, The p53 tumour suppressor gene. Nature (1991) 351: 453-6.
25. Lemoine NR, Molecular biology of breast cancer. Ann Oncol (1994) 5:531-7.